Document Detail


Practical strategies for the management of anticoagulation therapy: unsolved issues in the cardiac catheterization laboratory.
MedLine Citation:
PMID:  20390444     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Percutaneous coronary intervention (PCI) is the preferred reperfusion strategy in the management of patients with ST-elevation myocardial infarction (STEMI) and higher-risk patients with unstable angina/non-STEMI (UA/NSTEMI). Recent updates have been issued for guidelines from the American College of Cardiology and American Heart Association delineating the appropriate use of anticoagulants as ancillary therapies to PCI. This manuscript reviews the recent clinical trial data supporting the updated guidelines and highlights remaining areas of uncertainty. METHODS: SCOPUS and Pubmed were searched for relevant English-language reports of clinical trials, registries, articles and case reports. Search terms included but were not limited to: PCI, anticoagulation, ancillary, STEMI, NSTEMI, angina, acute coronary syndrome. The reference lists of identified articles were searched for additional relevant publications. RESULTS: Unfractionated heparin (UFH), the historical standard of care for anticoagulation in STEMI and NSTEMI patients undergoing PCI, is sub-optimal and the list of anticoagulants recommended for alternatives in the current guidelines has expanded to include superior anticoagulants, including the low-molecular-weight heparin enoxaparin and the direct thrombin inhibitor bivalirudin. Additionally, fondaparinux is recommended if supplemented during PCI by an additional agent with anti-IIa activity. However, uncertainties in the guidelines remain. Clinical discretion is still required when deciding which anticoagulant to use, ensuring seamless transitions throughout the care pathway, and how to correctly identify the risk status of a patient and modify anticoagulant regimens accordingly, such as in special patient populations. CONCLUSIONS: The published evidence supports the updates to the guidelines. Updated guidelines still have knowledge gaps which require the application of clinical discretion by the cardiologist.
Authors:
José G Díez; James M Wilson
Related Documents :
12482014 - Combination antiplatelet therapy: implications for pharmacists.
7661074 - Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagu...
9607504 - Pancreas divisum and stenosis of the major and minor papillae in an 8-year-old girl: tr...
10695504 - Anticoagulation after artificial valve replacement with or without atrial fibrillation:...
19942304 - Incidence and predictors of silent embolic cerebral infarction following diagnostic cor...
24112154 - Predicting value of serum soluble st2 and interleukin-33 for risk stratification and pr...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  24     ISSN:  1573-7241     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-06-22     Completed Date:  2010-11-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  161-74     Citation Subset:  IM    
Affiliation:
St. Luke's Episcopal Hospital, Texas Heart Institute, Baylor College of Medicine, 1709 Dryden Rd., BCM 620, Suite 9.40, Houston, TX 77030, USA. diez@bcm.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angina, Unstable / therapy*
Angioplasty, Transluminal, Percutaneous Coronary*
Anticoagulants / administration & dosage,  adverse effects,  therapeutic use*
Humans
Myocardial Infarction / therapy*
Chemical
Reg. No./Substance:
0/Anticoagulants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Correctional policy for offenders with mental illness: creating a new paradigm for recidivism reduct...
Next Document:  Maternal use of antibiotics and cancer in the offspring: results of a case-control study in Germany.